
Revolution Medicines is dedicated to discovering and delivering innovative targeted cancer therapies, focusing on RAS-addicted cancers.
Join the Revolution Medicines team as a Scientist II in the Translational Research team, working on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. As a cross-functional quantitative modeling group member, you will collaborate to develop, validate, and refine models to support discovery and development-phase projects.
Revolution Medicines is dedicated to discovering and delivering innovative targeted cancer therapies, focusing on RAS-addicted cancers.
Revolution Medicines